毛片免费毛片一级jjj毛片,日本在线亚州精品视频在线,国产精品国偷自产在线,久久精品色,日韩精品免费电影,欧美综合国产精品日韩一,国产六区

首頁 /藥靶模型 /激酶靶點(diǎn) /EGFR /EGFR WT (EGF Dependent)/BaF3_Discontinued

EGFR WT (EGF Dependent)/BaF3_Discontinued

CBP73166

詢 價(jià)
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫

I. Introduction
Cell Line Name: EGFR WT (EGF Dependent)/BaF3
Host Cell: BA/F3
Stability: 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Application: Anti-proliferation assay and PD assay
Freeze Medium: 90% FBS+10% DMSO
Complete Culture Medium: RPMI-1640+10%FBS+100ng/ml EGF
Mycoplasma Status: Negative
 
II. Background

EGFR is widely recognized for its importance in cancer. Amplification and mutations have been shown to be driving events in many cancer types. Its role in non-small cell lung cancer, glioblastoma and basal-like breast cancers has spurred many research and drug development efforts. Tyrosine kinase inhibitors have shown efficacy in EGFR amplfied tumors, most notably gefitinib and erlotinib. Mutations in EGFR have been shown to confer resistance to these drugs, particularly the variant T790M, which has been functionally characterized as a resistance marker for both of these drugs. The later generation TKI's have seen some success in treating these resistant cases, and targeted sequencing of the EGFR locus has become a common practice in treatment of non-small cell lung cancer. Overproduction of ligands is another possible mechanism of activation of EGFR. ERBB ligands include EGF, TGF-a, AREG, EPG, BTC, HB-EGF, EPR and NRG1-4 (for detailed information please refer to the respective ligand section). In ligand-activated cancers, Cetuximab appears to be more effective than tyrosine-kinase inhibitors.

 
III. Representative Data

1.WB of  EGFR WT (EGF Dependent)/BaF3

2. Anti-proliferation assay

Figure 2. Anti-proliferation assay of three reference compounds on the EGFR WT (EGF Dependent)/BaF3 Stable Cell Line.


客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理(上海):18240630236 華東銷售經(jīng)理(上海、江蘇、安徽):15715191010 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 華北銷售經(jīng)理:18628311252 全國(guó)銷售經(jīng)理:13816461235
診斷標(biāo)準(zhǔn)品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18628311252 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 全國(guó)銷售經(jīng)理:13816461235

掃二維碼

立即提交
定边县| 巩留县| 石家庄市| 泸定县| 天全县| 贵港市| 循化| 兰州市| 驻马店市| 苗栗县| 八宿县| 武义县| 太仆寺旗| 石楼县| 襄樊市| 潼关县| 龙陵县| 龙门县| 镇巴县| 宁海县| 远安县| 大冶市| 溧阳市| 霍邱县| 阜城县| 海兴县| 自贡市| 定结县| 介休市| 南部县| 勐海县| 嵊州市| 临邑县| 江川县| 大关县| 宁夏| 普陀区| 永城市| 宁化县| 桦川县| 新巴尔虎左旗|